6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Abburi Naga Pranathi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fluoro & Agro Chemicals Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Pyrimidines, Nitriles, Molecular Docking Simulation, Microbial Sensitivity Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Council of Scientific and industrial Research (CSIR), DST-INSPIRE.
Abstract (Originalsprache)
This report explores the potential of novel 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile scaffolds as promising anti‐infective agents in the face of the increasing threat of infectious diseases. Starting from 2‐amino‐4,6‐dichloropyrimidine, a series of 24 compounds inspired from the antiviral drugs dapivirine, etravirine, and rilpivirine were designed and synthesized via a two‐step reaction sequence in good yields. Biological testing of synthetic analogs revealed potent inhibition against both viral and tuberculosis targets. Notably, compounds 5p (2,4‐dimethyl substitution; IC 50 = 44 ± 4.9 µM; selectivity index [SI] = 20) and 5 s (3‐thiophenphenyl; IC 50 = 6 ± 1 µM; SI = 120) showed significant antiviral activity against pandemic influenza virus A/Puerto Rico/8/34 (H1N1) with positive toxicity profiles and also exhibited good IC 50 values ( 5p , IC 50 = 10 ± 2 µM; SI = 9 and 5 s , IC 50 = 16 ± 2 µM; SI = 60) against the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (Wuhan strain) compared with favipiravir. In addition, analogs 5a , 5r , 5t , and 5u showed good antitubercular activity against Mycobacterium tuberculosis H37Rv strain and compounds 3 , 5f , 5n , and 5q showed moderate antibacterial activity against gram+ve and gram‐ve bacterial strains, suggesting that this scaffold has a broad spectrum of therapeutic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fluoro & Agro Chemicals Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Pasteur Institute of Epidemiology and Microbiology, St. Petersburg, Russia.
- Centre for X-ray Crystallography, Analytical Chemistry Division, CSIR- Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
Förderung
- Council of Scientific and industrial Research (CSIR)
- DST-INSPIRE
Zitieren
APA
Pranathi, A. N., Devendra, N., Bollikanda, R. K., Bangalore, P. K., Esaulkova, I. L., Mikhalsky, M. G., Niukalova, M. A., Zarubaev, V. V., Sridhar, B., & Kantevari, S. (2025). 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400580
Vancouver
Pranathi AN, Devendra N, Bollikanda RK, Bangalore PK, Esaulkova IL, Mikhalsky MG, et al. 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400580
BibTeX
@article{Pranathi2025,
author = {Pranathi, Abburi Naga and Devendra, Nagineni and Bollikanda, Rakesh K and Bangalore, Pavan K and Esaulkova, Iana L and Mikhalsky, Mikhail G and Niukalova, Maria A and Zarubaev, Vladimir V and Sridhar, Balasubramanian and Kantevari, Srinivas},
title = {6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400580}
}
EUVIMED